An anti-IL-2-receptor antibody to prevent organ-transplant rejection
Basiliximab
An antibody infusion given around an organ transplant to help prevent the body rejecting the new organ.
What is Basiliximab?
Basiliximab is a specialist medicine used to help prevent rejection of a transplanted organ, such as a kidney. It is a monoclonal antibody that blocks a receptor (the IL-2 receptor) on certain immune cells, dampening the early immune response that would otherwise attack the new organ. It is given as a short course of infusions into a vein around the time of the transplant, alongside other anti-rejection (immunosuppressant) medicines. It is generally well tolerated; serious allergic reactions are rare but possible, so it is given where staff can watch for them.
Education and reference only. This is a plain-language guide to Basiliximab — it deliberately contains no doses. Doses depend on the person, the brand and the reason for treatment, and belong with your prescriber. Always check the BNF, the product labelling (SmPC) and follow medical advice.
What it is
Basiliximab is a monoclonal antibody, a laboratory-made protein, used to help prevent the body's immune system from rejecting a newly transplanted organ, most often a kidney. After a transplant, the immune system can recognise the new organ as foreign and attack it; basiliximab is given to reduce the risk of this happening in the critical early period. It is given as an infusion (drip) into a vein, usually as a short course around the time of the transplant, and is used together with other anti-rejection medicines. It is a hospital-based, specialist treatment supervised by the transplant team.
How it works
When the immune system reacts to a new organ, certain immune cells (T cells) are stimulated to multiply by a signalling chemical called interleukin-2 (IL-2), which acts through a receptor on their surface. Basiliximab attaches to part of that IL-2 receptor and blocks the signal, so these cells are less able to multiply and mount an attack on the transplanted organ. This dampens the early immune response at the time it matters most. Because it works for a limited period, it is given as a short course around the transplant alongside longer-term anti-rejection medicines.
Company & origin
Originated / developed by: Specialist manufacturer.
A specialist infusion used in the UK around the time of an organ transplant to help prevent rejection, given by transplant teams.
Practical use
How to take Basiliximab
General, dose-free guidance — always follow your prescriber's and the leaflet's specific instructions.
- It is given as a drip into a vein by your transplant team, as a short course around the time of your transplant.
- Keep taking your other anti-rejection (immunosuppressant) medicines exactly as prescribed.
- Tell staff at once about any reaction during or shortly after the drip, such as flushing, rash or breathlessness.
- Report any signs of infection to your transplant team, as your immune system is dampened.
- Attend all your follow-up appointments and blood tests after the transplant.
Weighing it up
Advantages & disadvantages of Basiliximab
Advantages
- Helps prevent rejection of a transplanted organ during the critical early period.
- Generally well tolerated and given as a short course around the transplant.
- Targets a specific immune signal, working alongside other anti-rejection medicines.
Disadvantages
- Can rarely cause serious allergic reactions, so it is given under close watch.
- Works only for a limited time, so longer-term anti-rejection medicines are still needed.
- Given as a hospital infusion under specialist supervision.
Practical use
Good to know
Basiliximab is generally well tolerated and, on its own, does not tend to add greatly to the side effects of the other anti-rejection medicines it is given with. The main safety point is that serious allergic (hypersensitivity) reactions can rarely happen, so it is given where staff can watch for and treat them, and any future doses are given with care if there has been a reaction before. It is used as part of a package of anti-rejection treatment, not by itself, so it is important to keep taking your other immunosuppressant medicines exactly as prescribed. As with all anti-rejection treatment, the immune system is dampened, so it makes sense to report signs of infection to your transplant team and to keep all your follow-up appointments and blood tests.
Who should not take it / use with caution
- People who have had a serious allergic reaction to basiliximab should not receive it again.
- It is used with care in people with an active infection, which the team will assess.
- It is used with care in pregnancy and breastfeeding, with the specialist weighing benefits and risks.
Monitoring
- Watching for allergic reactions during and after the infusions.
- Monitoring for signs of rejection and infection after the transplant.
- Regular blood tests and follow-up as part of transplant care.
Side effects
- It generally adds few side effects of its own beyond those of the other anti-rejection medicines.
- Rarely, serious allergic (hypersensitivity) reactions, which is why it is given under close watch.
- Effects related to a dampened immune system, such as a higher chance of infection, shared with other anti-rejection treatment.
Key interactions
- It is used together with other anti-rejection (immunosuppressant) medicines as part of a planned regimen.
- Live vaccines are generally avoided while the immune system is dampened, so check before any vaccination.
- Tell your team about all your medicines so they fit safely with your transplant treatment.
Available as: A powder made up into a solution for infusion (drip) into a vein in hospital.
Answers
Basiliximab: frequently asked questions
What is basiliximab used for?
It is used to help prevent rejection of a newly transplanted organ, such as a kidney, by dampening the early immune response that would otherwise attack it.
How is it given?
It is given as a short course of infusions into a vein by your transplant team around the time of the transplant, alongside other anti-rejection medicines.
Does it replace my other anti-rejection medicines?
No. It works for a limited period around the transplant and is used together with, not instead of, your longer-term anti-rejection medicines.
Is it safe?
It is generally well tolerated; serious allergic reactions are rare but possible, so it is given where staff can watch for and treat them.
Will it affect vaccines?
Because the immune system is dampened, live vaccines are generally avoided, so always check with your transplant team before any vaccination.
Authoritative sources
- BNF
- NICE CKS
Building a medicines information resource?
We create evidence-led, dose-free drug and formulary references for teams.